Joey Dizenhouse, FSA, MAAA

I sat down with Joey Dizenhouse, CEO of SlateRx, to talk about redefining pharmacy benefits—minus the gimmicks. We dug into transparency, real fiduciary alignment, and how SlateRx is tackling PBM dysfunction head-on. If you're tired of smoke and mirrors in the benefits space, this episode is for you. Sponsored by WaypointRx.

Host Mike Koelzer speaks with Joey Dizenhouse, an actuary and PBM expert, about the intricate relationships between PBMs, pharmacies, and plan sponsors Negotiation requires leverage, subject matter expertise, and tenacity Joey explains his role in negotiating master agreements between PBMs and the entity with their insurance plan, ensuring the incentives of the PBM align with the best interests of the plan and its members Negative impact of choosing brand name drugs over cheaper generics o...